Work

Abstract 3150: InVEST44™ is a cost-effective in vitro safety panel that identifies off-target effects in early-stage drug discovery

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-3150

Authors: Julian R. Wooltorton, Afsara Ahona, Nicole Barbacane, Alex D'Andrea, Justin Lansberry, Cindy Lay, Paige Miller, John Ries, Jamin Steffen, Patricia Valentine

Institution: Reaction Biology Corporation (United States)

Language: English

Topic: Animal testing and alternatives

Subfield: Small Animals

Field: Veterinary

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148651912

Cites:

Cited by:

Related to: